For patients or family members, what they are most concerned about is the cure rate and survival rate of lymphoma. Although these are only reference values, they also allow people to be mentally prepared and muster up confidence to fight the disease together. We explain to you the prognosis, cure rate and survival rate of two major lymphomas: Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.
Hodgkin’s lymphoma has high cure rate and survival rate
The prognosis of patients with Hodgkin’s lymphoma is generally good. On the one hand, the peak age of incidence is between 20 and 30 years old. Compared with patients with non-Hodgkin’s lymphoma, which mostly develop in older people, the treatment options available for the former are The greater the number, the better the recovery after surgery.
Not only that, Hodgkin’s lymphoma is not easy to metastasize, and it responds well to radiation therapy, reducing the possibility of recurrence after surgery.
Overall, if Hodgkin’s patients are diagnosed in the early stages (stages one and two), the treatment success rate can reach 80%. Even if the disease is diagnosed in the third or fourth stages, the patient’s 10-year survival rate is 50% respectively. Or 60%; therefore, cancer patients do not need to be discouraged. As long as they actively cooperate with treatment, the chance of successfully fighting cancer is not low.
Non-Hodgkin’s lymphoma is more deadly
Non-Hodgkin’s lymphoma is of moderate to high malignancy, also known as “aggressive lymphoma”. Therefore, it develops quickly and has a high fatality rate.
Currently, CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone) chemotherapy is mainly used together with anti-CD20 monoclonal antibodies. However, because patients with non-Hodgkin’s disease are usually older, the dose of chemotherapy drugs may need to be reduced. , which also relatively increases the chance of lymphoma recurrence.
How long can you live with stage 4 lymphoma? Non-Hodgkin’s Lymphoma Survival Rates
Patients with low-malignancy non-Hodgkin’s lymphoma have a 5-year survival rate of about 70%. However, because they are more likely to metastasize and relapse, they need to be mentally prepared for a long-term battle. If tumors of medium and high malignancy can be treated early, Most patients have significant improvement after chemotherapy. It is even easier to completely eliminate cancer cells and achieve a cure than low-malignancy lymphoma. However, if lymphoma is not discovered until the fourth (terminal) stage, survival will be difficult. The rate may only be 20%.
The above are all statistics. Fighting cancer not only relies on the professionalism of doctors, but also the confidence of patients and the support of their families are important factors that affect the results of treatment. In addition to conventional medical treatment, some patients will also turn to folk therapies. It is recommended that patients discuss it in detail with their doctors first to avoid affecting the normal course of treatment and causing unnecessary risks.